Brief: Wanbury Expanded Regulatory Submission For New Active Pharmaceutical Ingredients
09/06/2026 10:39
BRIEF-Wanbury Expanded Regulatory Submission For New Active Pharmaceutical Ingredients June 9 (Reuters) - Wanbury Ltd WANB.NS:
WANBURY - EXPANDED REGULATORY SUBMISSION FOR NEW ACTIVE PHARMACEUTICAL INGREDIENTS
WANBURY LTD - FOR DIPHENHYDRAMINE HCL, COMPANY SUBMITTED DMF TO MALAYSIA AND SINGAPORE
WANBURY - TO SUBMIT DMFS FOR PAROXETINE HCL IN KOREA AND LATIN AMERICA
Source text: ID:nBSE6ZP8yc
Further company coverage: WANB.NS
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Wanbury
See all newsBrief: Wanbury Ltd Receives 9 “No DMF Deficiency” Letters From USFDA For Metformin HCl
Brief: Wanbury Files New Drug Master File In South Africa For Tramadol Hcl API
Brief: Wanbury June-Quarter PAT 32.4 Million Rupees
Brief: Wanbury Receives No DMF Deficiency Letter From USFDA For Multiple Andas
Brief: Wanbury Says Completion Of US FDA Inspection At Tanuku Facility